SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : MDA - Market Direction Analysis -- Ignore unavailable to you. Want to Upgrade?


To: mishedlo who wrote (81051)7/31/2001 9:26:42 AM
From: LTK007  Read Replies (2) | Respond to of 99985
 
one wants to see well rounded bottoms,is what my eye likes to see.max



To: mishedlo who wrote (81051)7/31/2001 9:27:51 AM
From: Boplicity  Read Replies (2) | Respond to of 99985
 
I haven't shifted gears. The Dow, S&P 500, and NAZ made firm bottoms in April we might even test them, that would be good then we might get out of the range bound market we are in, but I don't think a test is in the cards, therefore the sideways call. I have been saying for a couple of months now that the market will be going sideways for sometime. What I was trying to point out last night is that during periods like we have now keying on the averages will only serve to exercises your yawning muscles and there are many stocks to be had, that have moved solidly off the bottom or are starting to move now, and will continue to move while the market bases. Do you remember me saying the market was going to enter into a base building period many moons ago? That's what we are in now, and I feel we will be in this type of market that is ranged bound for sometime.

B



To: mishedlo who wrote (81051)8/1/2001 9:01:41 AM
From: Boplicity  Read Replies (1) | Respond to of 99985
 
08:53 ET Krispy Kreme (KKD) 28.20: Dain Rauscher Wessels upgrades to STRONG BUY-AGGRESSIVE from Buy-Aggressive, cites continued strong near and long-term fundamental outlook and a more attractive valuation following recent price weakness (stock fell 30% in July).